We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+21.94%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$128M
Cap. Flow
+$26.2M
Cap. Flow %
2.17%
Top 10 Hldgs %
56.76%
Holding
362
New
28
Increased
88
Reduced
207
Closed
28

Top Buys

Rank Stock Value
1
TME icon
Tencent Music
TME
+$28.3M
2
LEGN icon
Legend Biotech
LEGN
+$20.2M
3
TCOM icon
Trip.com Group
TCOM
+$16M
4
STAA icon
STAAR Surgical
STAA
+$10.7M
5
ZLAB icon
Zai Lab
ZLAB
+$7.74M

Top Sells

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$21.9M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.8M
3
NIO icon
NIO
NIO
+$10.3M
4
LI icon
Li Auto
LI
+$8.53M
5
BZ icon
Kanzhun
BZ
+$8.18M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.91%
2 Technology 25.51%
3 Communication Services 14.94%
4 Healthcare 9.44%
5 Real Estate 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWST icon
176
Twist Bioscience
TWST
$5.62B
$410K 0.03%
17,231
+6,414
+59% +$186K
VIR icon
177
Vir Biotechnology
VIR
$1.47B
$409K 0.03%
16,178
-5,106
-24% -$125K
MELI icon
178
Mercado Libre
MELI
$91.3B
$405K 0.03%
478
-27
-5% -$24K
FIS icon
179
Fidelity National Information Services
FIS
$21.5B
$403K 0.03%
5,938
-208
-3% -$14.8K
PANW icon
180
Palo Alto Networks
PANW
$264B
$401K 0.03%
5,746
-242
-4% -$19.4K
PCAR icon
181
PACCAR
PCAR
$69.6B
$395K 0.03%
5,991
-324
-5% -$21.2K
CERE
182
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$395K 0.03%
12,509
+2,109
+20% +$59.5K
AZN icon
183
AstraZeneca
AZN
$263B
$394K 0.03%
2,902
+6
+0.2% +$752
BMY icon
184
Bristol-Myers Squibb
BMY
$127B
$393K 0.03%
5,465
-717
-12% -$54.1K
BEAM icon
185
Beam Therapeutics
BEAM
$2.58B
$392K 0.03%
10,035
+1,752
+21% +$78.5K
BLUE
186
DELISTED
bluebird bio
BLUE
$391K 0.03%
2,822
-514
-15% -$72.4K
BPMC
187
DELISTED
Blueprint Medicines
BPMC
$391K 0.03%
8,928
+2,666
+43% +$128K
MYOV
188
DELISTED
Myovant Sciences Ltd.
MYOV
$391K 0.03%
14,510
+3,357
+30% +$88.3K
IOVA icon
189
Iovance Biotherapeutics
IOVA
$2.23B
$389K 0.03%
60,952
+18,421
+43% +$144K
WMT icon
190
Walmart Inc
WMT
$871B
$389K 0.03%
8,223
-435
-5% -$20.7K
NTLA icon
191
Intellia Therapeutics
NTLA
$1.5B
$387K 0.03%
11,103
+3,710
+50% +$176K
EA icon
192
Electronic Arts
EA
$52.4B
$384K 0.03%
3,143
-220
-7% -$27.6K
VERV
193
DELISTED
Verve Therapeutics
VERV
$378K 0.03%
19,523
+7,231
+59% +$192K
MCD icon
194
McDonald's
MCD
$188B
$373K 0.03%
1,415
-75
-5% -$19.8K
RLAY icon
195
Relay Therapeutics
RLAY
$4.02B
$369K 0.03%
24,680
+11,197
+83% +$214K
TEL icon
196
TE Connectivity
TEL
$58.8B
$366K 0.03%
3,184
-55
-2% -$6.53K
DVAX
197
DELISTED
Dynavax Technologies
DVAX
$361K 0.03%
33,893
-6,995
-17% -$81.3K
LVS icon
198
Las Vegas Sands
LVS
$30.5B
$361K 0.03%
+7,516
New +$319K
WBA
199
DELISTED
Walgreens Boots Alliance
WBA
$360K 0.03%
9,638
-443
-4% -$16.7K
CSGP icon
200
CoStar Group
CSGP
$11.3B
$359K 0.03%
+4,643
New +$363K
6 7
8
9 10

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q4 2022 Portfolio in Review

As of Q4 2022, E Fund Management held 362 positions worth $1.2B, up 12% from $1.07B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

E Fund Management's Q4 2022 filing shows 28 new, 88 increased, 207 reduced and 28 closed positions. Its largest new stake was Akero Therapeutics: 9,604 shares worth $526K. The largest sale was KE Holdings, an estimated $21.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, up from 34% a quarter earlier, followed by Technology and Communication Services.

  • E Fund Management's largest Q4 2022 buy was Akero Therapeutics: 9,604 shares worth $526K.
  • E Fund Management added most to Tencent Music in Q4 2022, an estimated $28.3M increase.
  • E Fund Management's biggest Q4 2022 reduction was KE Holdings, cutting an estimated $21.9M.
  • E Fund Management fully exited Li Auto in Q4 2022, selling an estimated $8.53M.
  • E Fund Management's ten largest holdings make up 57% of its $1.2B portfolio in Q4 2022.
  • E Fund Management opened 28 new positions and closed 28 in Q4 2022.
  • E Fund Management's portfolio value rose 12% quarter-over-quarter to $1.2B.

Based on E Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.